View in EDS HTML Full Text PDF Full Text

THOR is a targetable epigenetic biomarker with clinical implications in breast cancer.

Saved in:

Bibliographic Details
Title:	THOR is a targetable epigenetic biomarker with clinical implications in breast cancer.
Authors:	Apolónio, Joana Dias^1,2,3,4 (AUTHOR), Dias, João S.⁵ (AUTHOR), Fernandes, Mónica Teotónio^2,3,6 (AUTHOR), Komosa, Martin^4,7 (AUTHOR), Lipman, Tatiana^4,7 (AUTHOR), Zhang, Cindy H.^4,7 (AUTHOR), Leão, Ricardo⁸ (AUTHOR), Lee, Donghyun^4,7 (AUTHOR), Nunes, Nuno Miguel^4,7 (AUTHOR), Maia, Ana-Teresa^1,3,9 (AUTHOR), Morera, José L.⁵ (AUTHOR), Vicioso, Luis¹⁰ (AUTHOR), Tabori, Uri^4,7,11 (AUTHOR), Castelo-Branco, Pedro^1,2,3,12 (AUTHOR) pjbranco@ualg.pt
Source:	Clinical Epigenetics. 12/18/2022, Vol. 14 Issue 1, p1-22. 22p.
Database:	Academic Search Ultimate
Full text is not displayed to guests. Login for full access.

Be the first to leave a comment!